Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

209.88
Delayed Data
As of Oct 20
 +4.70 / +2.29%
Today’s Change
119.37
Today|||52-Week Range
214.34
+63.92%
Year-to-Date

Today’s Trading

Previous close205.18
Today’s open205.58
Day’s range204.01 - 211.66
Volume727,020
Average volume (3 months)864,068
Market cap$30.7B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+9.56%
Earnings growth (next 5 years)+14.43%
Revenue growth (last year)+8.05%
P/E ratio42.1
Price/Sales7.90
Price/Book13.96

Competitors

----
BIVVBioverativ Inc+0.49+0.82%
EXASExact Sciences Corp+1.62+3.41%
BLUEbluebird bio Inc+3.10+2.22%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.99
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Executive VP-Operations, Products &
Strategy
Ostadan Omead
Corporate headquarters
San Diego, California

Forecasts